Infliximab single administration followed by acute liver injury.
Ierardi
Enzo
E
Della Valle
Nicola
N
Nacchiero
Maurizio Cosimo
MC
De Francesco
Vincenzo
V
Stoppino
Giuseppe
G
Panella
Carmine
C
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000009:adverse effects* / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D003093:Colitis, Ulcerative / Q000188:drug therapy; D006801:Humans; D000069285:Infliximab; D008099:Liver / Q000187:drug effects* / Q000201:enzymology* / Q000473:pathology; D008297:Male
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D000069285:Infliximab